# The Signal in the Extreme: A Systematic Outlier Framework Identifies Discrete Immunometabolic Subtypes in Human and Cellular Models

## TL;DR

This study shows that analyzing outliers in metabolic-inflammation data reveals hidden subtypes that traditional methods miss, offering new insights into disease mechanisms.

## Contribution

A novel framework for systematically analyzing outliers to identify discrete immunometabolic subtypes in complex diseases.

## Key findings

- An outlier subgroup in the clinical cohort showed hyperactivation of Th1/Th17 pathways and hypertriglyceridemia.
- Outlier samples in the cellular model exhibited IL-6 overproduction and IL-10 suppression.
- Multivariate analysis confirmed distinct spatial segregation of the identified immunometabolic profiles.

## Abstract

Background: Conventional omics analysis often treats outliers as noise, yet they may harbor critical biological insights. Objetive: This study proposes a paradigm shift: actively investigating outliers to discover biologically relevant subtypes within metabolic–inflammatory syndromes. Methods: We applied a comprehensive analytical framework for outlier detection based on a multi-algorithm consensus (IQR, MAD, Isolation Forest) to a clinical cohort of diabetic neuropathy (n = 93) and an in vitro 3T3-L1 adipocyte model (n = 39). The identified outliers were characterized using robust PCA, co-expression networks, unsupervised clustering, and Random Forest predictive modeling. Results: In the clinical cohort, an outlier subgroup (47.3%) exhibited an extreme immune–metabolic phenotype characterized by hyperactivation of Th1/Th17 pathways (elevated T-bet and IL-17; p < 0.001), hypertriglyceridemia, and network reconfiguration (TGFβ and STAT4 hubs). In the cellular model, outlier samples (12.8%) showed autonomous pro-inflammatory behavior characterized by IL-6 overproduction (p = 0.002) and IL-10 suppression. Conclusions: Multivariate analysis confirmed spatial segregation of these profiles. Systematic outlier investigation revealed discrete pathophysiological subtypes invisible to mean-focused analyses, demonstrating that extreme values encapsulate potent biological signals. This framework offers a generalizable approach for uncovering clinical heterogeneity and identifying therapeutic targets in complex diseases.